Back to results
US 2011/0212174 A1Published application
Controlled release arginine formulations
OwnerWayne H. KAESEMEYERinventor
Life of this patent
Estimating the term…
Abstract
A sustained release formulation of L-arginine alone or in combination with an agent which enhances the biotransformation of L-arginine into NO is described herein. FIG. 1A shows a schematic representation of proposed L-arginine dependent and independent pathways.
Claims20
A method for producing extended-release tablets comprising the steps of:
- mixing arginine with a sustained release matrix;
- and
- compressing said mixture to form tablets.
A composition comprised of arginine;
- and
- a sustained release polymeric matrix.
An extended-release pharmaceutical tablet comprised of a sustained release matrix and arginine.
Dependencies are inferred from the claim text.